vs
Side-by-side financial comparison of Maison Solutions Inc. (MSS) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $27.6M, roughly 1.4× Maison Solutions Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -18.0%, a 53.9% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -15.0%).
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MSS vs SBC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $39.6M |
| Net Profit | $-5.0M | $14.2M |
| Gross Margin | 23.4% | 73.1% |
| Operating Margin | -4.9% | 32.5% |
| Net Margin | -18.0% | 35.9% |
| Revenue YoY | -10.9% | -10.9% |
| Net Profit YoY | -1840.5% | 117.2% |
| EPS (diluted) | $-0.23 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.6M | $39.6M | ||
| Q3 25 | $27.2M | $43.4M | ||
| Q2 25 | $34.4M | $43.4M | ||
| Q1 25 | $32.3M | $47.3M | ||
| Q4 24 | $29.4M | $44.4M | ||
| Q3 24 | $28.2M | $53.1M | ||
| Q2 24 | $16.9M | $53.1M | ||
| Q1 24 | $13.6M | $54.8M |
| Q4 25 | $-5.0M | $14.2M | ||
| Q3 25 | $-1.5M | $12.8M | ||
| Q2 25 | $-287.4K | $2.5M | ||
| Q1 25 | $1.0M | $21.5M | ||
| Q4 24 | $-256.0K | $6.5M | ||
| Q3 24 | $700.9K | $2.8M | ||
| Q2 24 | $-2.8M | $18.5M | ||
| Q1 24 | $-549.0K | $18.8M |
| Q4 25 | 23.4% | 73.1% | ||
| Q3 25 | 24.1% | 70.6% | ||
| Q2 25 | 9.5% | 69.2% | ||
| Q1 25 | 21.8% | 79.7% | ||
| Q4 24 | 26.9% | 76.3% | ||
| Q3 24 | 28.9% | 81.5% | ||
| Q2 24 | 13.0% | 74.2% | ||
| Q1 24 | 23.4% | 72.1% |
| Q4 25 | -4.9% | 32.5% | ||
| Q3 25 | 0.7% | 36.6% | ||
| Q2 25 | -15.9% | 33.6% | ||
| Q1 25 | 3.7% | 51.1% | ||
| Q4 24 | 3.2% | 10.6% | ||
| Q3 24 | 7.3% | 26.1% | ||
| Q2 24 | -14.4% | 51.4% | ||
| Q1 24 | -2.3% | 44.6% |
| Q4 25 | -18.0% | 35.9% | ||
| Q3 25 | -5.7% | 29.6% | ||
| Q2 25 | -0.8% | 5.7% | ||
| Q1 25 | 3.1% | 45.4% | ||
| Q4 24 | -0.9% | 14.7% | ||
| Q3 24 | 2.5% | 5.3% | ||
| Q2 24 | -16.4% | 34.8% | ||
| Q1 24 | -4.0% | 34.2% |
| Q4 25 | $-0.23 | $0.15 | ||
| Q3 25 | $-0.08 | $0.12 | ||
| Q2 25 | $-0.02 | $0.02 | ||
| Q1 25 | $0.06 | $0.21 | ||
| Q4 24 | $-0.01 | $0.05 | ||
| Q3 24 | $0.04 | $0.03 | ||
| Q2 24 | $-0.16 | $0.20 | ||
| Q1 24 | $-0.03 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | $2.6M | $42.8M |
| Stockholders' EquityBook value | $11.6M | $248.3M |
| Total Assets | $75.4M | $380.4M |
| Debt / EquityLower = less leverage | 0.22× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | $1.1M | $127.4M | ||
| Q2 25 | $775.4K | $152.7M | ||
| Q1 25 | $445.4K | $132.1M | ||
| Q4 24 | $355.7K | $125.0M | ||
| Q3 24 | $588.9K | $137.4M | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $9.4M | — |
| Q4 25 | $2.6M | $42.8M | ||
| Q3 25 | $2.6M | $21.1M | ||
| Q2 25 | $2.6M | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $2.5M | $823.2K | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $11.6M | $248.3M | ||
| Q3 25 | $10.1M | $248.0M | ||
| Q2 25 | $11.7M | $244.6M | ||
| Q1 25 | $12.0M | $226.4M | ||
| Q4 24 | $10.9M | $195.1M | ||
| Q3 24 | $11.2M | $205.0M | ||
| Q2 24 | $10.5M | $8.8M | ||
| Q1 24 | $13.3M | $9.0M |
| Q4 25 | $75.4M | $380.4M | ||
| Q3 25 | $73.3M | $321.4M | ||
| Q2 25 | $77.4M | $315.3M | ||
| Q1 25 | $82.7M | $284.6M | ||
| Q4 24 | $82.7M | $266.1M | ||
| Q3 24 | $82.1M | $296.5M | ||
| Q2 24 | $82.4M | $19.5M | ||
| Q1 24 | $44.2M | $19.8M |
| Q4 25 | 0.22× | 0.17× | ||
| Q3 25 | 0.26× | 0.09× | ||
| Q2 25 | 0.22× | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | 0.23× | 0.00× | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | $52.0M | ||
| Q3 25 | $1.1M | $-20.9M | ||
| Q2 25 | $-1.6M | $-8.3M | ||
| Q1 25 | $1.7M | $1.9M | ||
| Q4 24 | $1.1M | $-7.3M | ||
| Q3 24 | $3.6M | $5.0M | ||
| Q2 24 | $-2.6M | $19.2M | ||
| Q1 24 | $-1.4M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | 1.66× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 5.12× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
